Sutro Biopharma Shareholders Equity (Quarterly) Analysis

Sutro Biopharma Inc (STRO)

3.83 -0.11 (-2.79%) USD | NASDAQ | May 03, 16:00

3.84 +0.01 (+0.26%) After-Hours: 20:00

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	149.65M
September 30, 2023	112.35M
June 30, 2023	154.72M
March 31, 2023	185.41M
December 31, 2022	217.05M
September 30, 2022	229.73M
June 30, 2022	209.06M
March 31, 2022	220.37M
December 31, 2021	252.56M
September 30, 2021	283.58M
June 30, 2021	307.50M
March 31, 2021	307.34M

Date	Value
December 31, 2020	332.05M
September 30, 2020	244.12M
June 30, 2020	206.76M
March 31, 2020	82.08M
December 31, 2019	97.79M
September 30, 2019	109.91M
June 30, 2019	119.56M
March 31, 2019	130.72M
December 31, 2018	131.54M
September 30, 2018	-141.43M
June 30, 2018	-132.02M
December 31, 2017	-109.00M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

82.08M

Minimum

Mar 2020

332.05M

Maximum

Dec 2020

201.14M

Average

209.06M

Median

Jun 2022

Shareholders Equity (Quarterly) Benchmarks

AnaptysBio Inc	88.10M
ABVC BioPharma Inc	8.388M
Reviva Pharmaceuticals Holdings Inc	5.719M
Flora Growth Corp	6.404M
Journey Medical Corp	20.35M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	470.74M
Total Liabilities (Quarterly)	321.09M
Debt to Equity Ratio	0.0271
Current Ratio	4.497
Net Debt Paydown Yield	1.16%